market

The biopharma contract manufacturing market is expected to grow at an annualized rate of more than 8%.

Roots Analysis has announced the addition of “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030” report to its list of offerings. Souvik Mohanta, the principal analyst, stated, “Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth […]

The biopharma contract manufacturing market is expected to grow at an annualized rate of more than 8%. Read More »

The “Oligonucleotide Synthesis, Modification and Purification Services Market, Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030

To order this 300+ page report, please visit this link Key Inclusions A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications. It features information on the year of establishment, company size, scale of operation (preclinical, clinical, and commercial), location of headquarters,

The “Oligonucleotide Synthesis, Modification and Purification Services Market, Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030 Read More »

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge. To order this 300+ page report, which

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations Read More »

The oligonucleotide synthesis, modification and purification services market is projected to grow at an annualized rate of ~10%,

Roots Analysis has done a detailed study on “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this link Key Market

The oligonucleotide synthesis, modification and purification services market is projected to grow at an annualized rate of ~10%, Read More »

The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030

The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs Roots Analysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modification and Purification Services Market:

The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030 Read More »

The oligonucleotide synthesis, modification and purification services market is projected to be worth USD 5.8 billion

The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting up manufacturing facilities, has generated a range of new opportunities for custom manufacturers London Roots Analysis has announced the addition of the “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030”

The oligonucleotide synthesis, modification and purification services market is projected to be worth USD 5.8 billion Read More »

The “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this link Key Inclusions A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, purpose of manufacturing (in-house and contract

The “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030 Read More »

Over 60 companies across the globe claim to manufacture drug products / drug substances using the continuous manufacturing technique

The COVID-19 pandemic has severely impaired the overall pharmaceutical supply chain, mostly owing to the absence of workers at manufacturing sites and restrictions imposed on distribution networks. In this context, continuous manufacturing offers a viable solution given the fact that continuous processes are largely automated. In fact, the FDA (and other regulatory bodies) have also

Over 60 companies across the globe claim to manufacture drug products / drug substances using the continuous manufacturing technique Read More »

The continuous manufacturing market is projected to grow at an annualized rate of over 15%, till 2030

Roots Analysis has done a detailed study on Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030, covering key aspects of the industry and identifying future growth opportunities. To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this link Key Market Insights Eminent representatives from prominent contract service

The continuous manufacturing market is projected to grow at an annualized rate of over 15%, till 2030 Read More »

The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis

Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing Roots Analysis is pleased to announce the publication of its recent study, titled, “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030.” The report features an

The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis Read More »